The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: Results from three tuberculosis-HIV transmission models

AIDS

Volumn 28, Issue SUPPL. 1, 2014, Pages

  Pretorius, Carel ^a   Menzies, Nicolas A ^b   Chindelevitch, Leonid ^b   Cohen, Ted ^b,c   Cori, Anne ^d   Eaton, Jeffrey W ^e   Fraser, Christophe ^d   Gopalappa, Chaitra ^a   Hallett, Timothy B ^e   Salomon, Joshua A ^b   Stover, John ^a   White, Richard G ^f   Dodd, Peter J ^f  

^a AVENIR HEALTH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antiretroviral therapy; HIV; mathematical models; South Africa; tuberculosis

Indexed keywords

ANTIRETROVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MATHEMATICAL MODEL; MORTALITY; PHARMACEUTICAL CARE; PRIORITY JOURNAL; SOUTH AFRICA; TUBERCULOSIS;

ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; HEALTH POLICY; HIV INFECTIONS; HUMANS; INCIDENCE; MODELS, THEORETICAL; SECONDARY PREVENTION; SOUTH AFRICA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS; VIRAL LOAD;

EID: 84893299973     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000085     Document Type: Article

References (37)

1. WHO. WHO Global TB Database; 2011. http://www.who.int/tb/country/data/ download/en/index.html [Accessed on 4 April 2013].
2. Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Sangweni P, et al. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS 2010; 24:1849-1855.
3. Department of Health. Tuburculosis strategic plan for South Africa, 2007-2011. Pretoria South Africa: South African Department of Health; 2007.
4. Ntshanga SP, Rustomjee R, Mabaso MLH. Evaluation of directly observed therapy for tuberculosis in KwaZulu-Natal, South Africa. Trans Royal Soc Trop Med Hygiene 2009; 103:571-574.
5. Wood R, Lawn SD, Johnstone-Robertson S, Bekker L-G. Tuberculosis control has failed in South Africa: Time to reappraise strategy. S Afr Med J 2011; 101:111-114.
6. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restrictionfragment-length polymorphisms. New Engl J Med 1992; 326: 231-235.
7. Bucher HC, Griffith LE, Guyatt GH, Sudre P, Naef M, Sendi P, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: A meta-analysis of randomized controlled trials. AIDS 1999; 13:501-507.
8. Shafer RW, Singh SP, Larkin C, Small PM. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient. Tuber Lung Dis 1995; 76:575-577.
9. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-1021.
10. Manosuthi W, Tantanathip P, Chimsuntorn S, Eampokarap B, Thongyen S, Nilkamhang S, et al. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: A four-year prospective study. Int J Infect Dis 2010; 14:e1013-e1017.
11. Van Der Sande MA, Schim Van Der Loeff MF, Bennett RC, Dowling M, Aveika AA, Togun TO, et al. Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS 2004; 18:1933-1941.
12. Williams BG, Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science (New York, NY) 2003; 301:1535-1537.
13. Williams BG, Granich R, De Cock KM, Glaziou P, Sharma A, Dye C. Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci USA 2010; 107:19485-19489.
14. Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: A systematic review and meta-analysis. PLOS Med 2012; 9:e1001270.
15. Gupta A, Wood R, Kaplan R, Bekker L-G, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: Comparison with rates in the community. PLOS ONE 2012; 7:e34156.
16. Wood R, Lawn SD. Antiretroviral treatment as prevention: Impact of the test and treat strategy on the tuberculosis epidemic. Curr HIV Res 2011; 9:383-392.
17. UNAIDS, UNAIDS Report on the Global AIDS Epidemic 2012, Geneva.
18. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach, 2006 revision. Geneva: World Health Organization; 2006.
19. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach: 2010 revision. Geneva: World Health Organization; 2010.
20. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
21. Anglemyer A, Rutherford GW, Baggaley RC, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane DB Syst Rev 2011 CD009153.
22. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva: World Health Organization; 2013.
23. Currie CSM, Floyd K, Williams BG, Dye C. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC Public Health 2005; 5:130.
24. Currie CSM, Williams BG, Cheng RCH, Dye C. Tuberculosis epidemics driven by HIV: Is prevention better than cure AIDS 2003; 17:2501-2508.
25. Bacaer N, Ouifki R, Pretorius C, Wood R, Williams B. Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol 2008; 57:557-593.
26. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models. Lancet Glob Health 2014; 2:e23-e34.
27. Department of Health. The South African Antiretroviral Treatment Guidelines 2013. Pretoria, South Africa: South African Department of Health; 2013.
28. South Africa National AIDS Council. National Strategic Plan on HIV, STIs and TB 2012-2016. South Africa: Johannesburg; 2011.
29. Menzies NA, Cohen T, Lin H-H, Murray M, Salomon JA. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: A dynamic simulation and economic evaluation. PLOS Med 2012; 9:e1001347.
30. Ayles HM, Sismanidis C, Beyers N, Hayes RJ, Godfrey-Faussett P. ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: Design of a 2 x 2 factorial community randomized trial. Trials 2008; 9:63.
31. Stover J, McKinnon R, Winfrey B. Spectrum: A model platform for linking maternal and child survival interventions with AIDS, family planning and demographic projections. Int J Epidemiol 2010; 39 (Suppl 1):i7-10.
32. Haddow LJ, Moosa M-YS, Mosam A, Moodley P, Parboosing R, Easterbrook PJ. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLOS ONE 2012; 7:e40623.
33. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: Case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8:516-523.
34. Birnbaum JK, Murray CJ, Lozano R. Exposing misclassified HIV/AIDS deaths in South Africa. Bull World Health Organ 2011; 89:278-285.
35. Burger EH, Van Der Merwe L, Volmink J. Errors in the completion of the death notification form. S Afr Med J 2007; 97:1077-1081.
36. Yudkin PL, Burger EH, Bradshaw D, Groenewald P, Ward AM, Volmink J. Deaths caused by HIV disease under-reported in South Africa. AIDS 2009; 23:1600-1602.
37. Statistics South Africa. Mortality and causes of death in South Africa 2010: Findings from death notification. Pretoria South Africa: Statistics South Africa; 2013.